Furthermore, it has been demonstrated that the transitional B cells from individuals with SLE have abnormal phenotypes, including lower CD19 expression and impaired sensitivity to TLR9 stimuli (98). The gene discussed is CD19; the disease is systemic lupus erythematosus.